- Home
- RSLS vs PSTV Comparison
RSLS vs PSTV Comparison
Compare RSLS & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RSLS
- PSTV
- Stock Information
- Founded
- RSLS 2002
- PSTV 1996
- Country
- RSLS United States
- PSTV United States
- Employees
- RSLS N/A
- PSTV N/A
- Industry
- RSLS Medical/Dental Instruments
- PSTV Medical/Dental Instruments
- Sector
- RSLS Health Care
- PSTV Health Care
- Exchange
- RSLS Nasdaq
- PSTV Nasdaq
- Market Cap
- RSLS 4.5M
- PSTV 5.1M
- IPO Year
- RSLS 2007
- PSTV N/A
- Fundamental
- Price
- RSLS $4.31
- PSTV $0.37
- Analyst Decision
- RSLS Hold
- PSTV Strong Buy
- Analyst Count
- RSLS 1
- PSTV 3
- Target Price
- RSLS N/A
- PSTV $12.75
- AVG Volume (30 Days)
- RSLS 101.4K
- PSTV 11.7M
- Earning Date
- RSLS 05-21-2025
- PSTV 05-30-2025
- Dividend Yield
- RSLS N/A
- PSTV N/A
- EPS Growth
- RSLS N/A
- PSTV N/A
- EPS
- RSLS N/A
- PSTV N/A
- Revenue
- RSLS $7,175,000.00
- PSTV $5,206,000.00
- Revenue This Year
- RSLS $52.80
- PSTV $13.26
- Revenue Next Year
- RSLS N/A
- PSTV $8.84
- P/E Ratio
- RSLS N/A
- PSTV N/A
- Revenue Growth
- RSLS N/A
- PSTV N/A
- 52 Week Low
- RSLS $4.03
- PSTV $0.24
- 52 Week High
- RSLS $414.99
- PSTV $2.67
- Technical
- Relative Strength Index (RSI)
- RSLS 34.73
- PSTV 40.90
- Support Level
- RSLS $4.34
- PSTV $0.28
- Resistance Level
- RSLS $4.95
- PSTV $0.37
- Average True Range (ATR)
- RSLS 0.53
- PSTV 0.09
- MACD
- RSLS 0.19
- PSTV 0.00
- Stochastic Oscillator
- RSLS 10.11
- PSTV 21.98
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).